493 related articles for article (PubMed ID: 34440863)
1. Hidradenitis Suppurativa: Where We Are and Where We Are Going.
Scala E; Cacciapuoti S; Garzorz-Stark N; Megna M; Marasca C; Seiringer P; Volz T; Eyerich K; Fabbrocini G
Cells; 2021 Aug; 10(8):. PubMed ID: 34440863
[TBL] [Abstract][Full Text] [Related]
2. Aetiology and pathogenesis of hidradenitis suppurativa.
Wolk K; Join-Lambert O; Sabat R
Br J Dermatol; 2020 Dec; 183(6):999-1010. PubMed ID: 33048349
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
4. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis suppurativa.
González-López MA
Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
Giuffrida R; Cannavò SP; Coppola M; Guarneri C
Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
[TBL] [Abstract][Full Text] [Related]
7. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
[TBL] [Abstract][Full Text] [Related]
9. Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.
Thomi R; Cazzaniga S; Seyed Jafari SM; Schlapbach C; Hunger RE
JAMA Dermatol; 2018 May; 154(5):592-595. PubMed ID: 29617527
[TBL] [Abstract][Full Text] [Related]
10. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.
Melnik BC; Plewig G
Exp Dermatol; 2013 Mar; 22(3):172-7. PubMed ID: 23489419
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa.
Danby FW; Margesson LJ
Dermatol Clin; 2010 Oct; 28(4):779-93. PubMed ID: 20883920
[TBL] [Abstract][Full Text] [Related]
12. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of hidradenitis suppurativa: An update.
Prens E; Deckers I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S8-11. PubMed ID: 26470623
[TBL] [Abstract][Full Text] [Related]
14. Insights into hidradenitis suppurativa.
van Straalen KR; Prens EP; Gudjonsson JE
J Allergy Clin Immunol; 2022 Apr; 149(4):1150-1161. PubMed ID: 35189127
[TBL] [Abstract][Full Text] [Related]
15. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
[TBL] [Abstract][Full Text] [Related]
16. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322
[TBL] [Abstract][Full Text] [Related]
17. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
Shah A; Alhusayen R; Amini-Nik S
Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
[TBL] [Abstract][Full Text] [Related]
18. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
[TBL] [Abstract][Full Text] [Related]
20. What is hidradenitis suppurativa?
Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J
Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
